연구동향 분석

Comparison of Three Cardiovascular Risk Scores among HIV-Infected Patients in Korea: The Korea HIV/AIDS Cohort Study

배지윤 김수민 최윤수 Choi Jun Yong 김상일 김신우 박보영 최보율 최희정 2022년

논문상세정보
인용/피인용
' Comparison of Three Cardiovascular Risk Scores among HIV-Infected Patients in Korea: The Korea HIV/AIDS Cohort Study' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Coronary disease
  • Korea
  • cardiovasculardiseases
  • hiv
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
2,638 0

0.0%

' Comparison of Three Cardiovascular Risk Scores among HIV-Infected Patients in Korea: The Korea HIV/AIDS Cohort Study' 의 참고문헌

  • Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D : A : D study : a multi-cohort collaboration
  • Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation
    Nordell AD [2014]
  • Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells
    French MA [2009]
  • Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis
    Hsue PY [2009]
  • Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study
    Liu J [2004]
  • Predicting the risk of cardiovascular disease in HIV-infected patients : the data collection on adverse effects of anti-HIV drugs study
  • Morbidity and aging in HIV-infected persons : the Swiss HIV cohort study
    Hasse B [2011]
  • Long-term survival in HIV positive patients with up to 15Years of antiretroviral therapy
    McManus H [2012]
  • Level of agreement between frequently used cardiovascular risk calculators in people living with HIV
    Dhillon S [2019]
  • Korea HIV/AIDS Cohort Study: study design and baseline characteristics
    최보율 [2018]
  • Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection : exploratory analyses from the SMART trial
    Phillips AN [2008]
  • Inflammatory and coagulation biomarkers and mortality in patients with HIV infection
    Kuller LH [2008]
  • HIV infection and the risk of acute myocardial infarction
    Freiberg MS [2013]
  • Global burden of cardiovascular diseases : Part II : variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies
    Yusuf S [2001]
  • General cardiovascular risk profile for use in primary care : the Framingham Heart Study
  • Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte Ad, El-Sadr W, Thiébaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD. Class of antiretroviral drugs and the risk of myocardial infarction
  • Framingham equation model overestimates risk of ischemic heart disease in Korean men and women
    Ahn KA [2006]
  • Ethnic inequalities in acute myocardial infarction and stroke rates in Norway 1994-2009 : a nationwide cohort study(CVDNOR)
    Rabanal KS [2015]
  • Ethnic differences in risk factors and total risk of cardiovascular disease based on the Norwegian CONOR study
    Rabanal KS [2013]
  • Epidemiological characteristics of HIV infected Korean: Korea HIV/AIDS Cohort Study
    최윤수 [2019]
  • Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons
    Rotger M [2013]
  • Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy
    Begovac J [2015]
  • Cardiovascular risk prediction functions underestimate risk in HIV infection
    Triant VA [2018]
  • Cardiovascular risk in HIV-infected individuals: A comparison of three risk prediction algorithms
    Policarpo S [2019]
  • Cardiovascular risk assessment in HIVinfected male patients : a comparison of Framingham, SCORE, PROCAM and DAD risk equations
    Pirš M [2014]
  • Cardiovascular risk assessment : a comparison of the Framingham, PROCAM, and DAD equations in HIV-infected persons
    Nery MW [2013]
  • Cardiovascular disease risk profiles
    Anderson KM [1991]
  • CD4+ count-guided interruption of antiretroviral treatment
  • Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function : the D : A : D study
    Ryom L [2013]
  • Assessment of the agreement between the Framingham and DAD risk equations for estimating cardiovascular risk in adult Africans living with HIV infection : a cross-sectional study
    Noumegni SR [2017]
  • Assessment of cardiovascular risk factors in people with HIV infection treated with ART in rural South Africa : a cross sectional study
    Mashinya F [2015]
  • An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons : The data-collection on adverse effects of anti-HIV drugs(D : A : D)study
  • A coronary heart disease prediction model : the Korean Heart Study
    Jee , S. H. [2014]
  • A comparison of the predicted risk for cardiovascular disease between HIV-infected and uninfected persons in Korea
    Kim SB [2013]